Erika Terzuoli

1.3k total citations
29 papers, 998 citations indexed

About

Erika Terzuoli is a scholar working on Pharmacology, Oncology and Cancer Research. According to data from OpenAlex, Erika Terzuoli has authored 29 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Erika Terzuoli's work include Inflammatory mediators and NSAID effects (10 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Erika Terzuoli is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Erika Terzuoli collaborates with scholars based in Italy, Sweden and United States. Erika Terzuoli's co-authors include Marina Ziche, Sandra Donnini, Antonio Giachetti, Lucia Morbidelli, Federica Finetti, Valerio Ciccone, Martina Monti, Giovanni Melillo, Liang Cao and Annamaria Rapisarda and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Erika Terzuoli

29 papers receiving 984 citations

Peers

Countries citing papers authored by Erika Terzuoli

Since Specialization

Citations

This map shows the geographic impact of Erika Terzuoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Terzuoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Terzuoli more than expected).

Fields of papers citing papers by Erika Terzuoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Terzuoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Terzuoli. The network helps show where Erika Terzuoli may publish in the future.

Co-authorship network of co-authors of Erika Terzuoli

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Terzuoli. A scholar is included among the top collaborators of Erika Terzuoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Terzuoli. Erika Terzuoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 2019 ·European Journal of Nutrition ·Erika Terzuoli, (unknown), Antonio Giachetti, Lucia Morbidelli, Marina Ziche, Sandra Donnini	30
2	mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 2019 ·Prostaglandins & Other Lipid Mediators ·Erika Terzuoli, (unknown), Valerio Ciccone, Marina Ziche, Lucia Morbidelli, Sandra Donnini	6
3	Pharmacological Tools for the Study of H2S Contribution to Angiogenesis 2019 ·Methods in molecular biology ·Lucia Morbidelli, Martina Monti, Erika Terzuoli	1
4	ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties 2018 ·Oxidative Medicine and Cellular Longevity ·(unknown), Erika Terzuoli, Valentina Giorgio, Sandra Donnini, Pietro Lupetti, Antonio Giachetti, Paolo Bernardi, Marina Ziche	26
5	Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 2018 ·Journal of Experimental & Clinical Cancer Research ·Valerio Ciccone, Erika Terzuoli, Sandra Donnini, Antonio Giachetti, Lucia Morbidelli, Marina Ziche	95
6	Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 2017 ·Nitric Oxide ·Erika Terzuoli, Federica Finetti, (unknown), Antonio Giachetti, Marina Ziche, Sandra Donnini	11
7	Development of Phenol-Enriched Olive Oil with Phenolic Compounds Extracted from Wastewater Produced by Physical Refining 2017 ·Nutrients ·Francesca Venturi, Chiara Sanmartin, Isabella Taglieri, (unknown), Gianpaolo Andrich, Erika Terzuoli, Sandra Donnini, Cristiano Nicolella, Angela Zinnai	44
8	H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 2016 ·Pharmacological Research ·Martina Monti, Erika Terzuoli, Marina Ziche, Lucia Morbidelli	34
9	Monitoring Endothelial and Tissue Responses to Cobalt Ferrite Nanoparticles and Hybrid Hydrogels 2016 ·PLoS ONE ·Federica Finetti, Erika Terzuoli, Sandra Donnini, (unknown), Marina Ziche, Lucia Morbidelli	24
10	Nitric Oxide and PGE-2 Cross-Talk in EGFR-Driven Epithelial Tumor Cells 2016 ·Critical Reviews™ in Oncogenesis ·Sandra Donnini, (unknown), Marina Ziche, Erika Terzuoli	4
11	Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and −186 expression: Novel mechanism of VEGF modulation in prostate cancer 2016 ·Oncotarget ·Erika Terzuoli, Sandra Donnini, Federica Finetti, Gabriella Nesi, Donata Villari, Hiromi Hanaka, Olof Rådmark, Antonio Giachetti, Marina Ziche	27
12	mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 2015 ·Endocrine Related Cancer ·Federica Finetti, Erika Terzuoli, Antonio Giachetti, Raffaella Santi, Donata Villari, Hiromi Hanaka, Olof Rådmark, Marina Ziche, Sandra Donnini	37
13	Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H₂S availability 2015 ·British Journal of Pharmacology ·Erika Terzuoli, Martina Monti, Valentina Vellecco, Mariarosaria Bucci, Giuseppe Cirino, Marina Ziche, Lucia Morbidelli	35
14	Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation 2014 ·PLoS ONE ·Erika Terzuoli, Stefania Meini, Paola Cucchi, Claudio Catalani, (unknown), Carlo Alberto Maggi, Antonio Giachetti, Marina Ziche, Sandra Donnini	45
15	The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 2013 ·Pharmacological Research ·Martina Monti, Erika Terzuoli, Marina Ziche, Lucia Morbidelli	30
16	Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis 2012 ·PLoS ONE ·Federica Finetti, Erika Terzuoli, Elena Bartoloni, Isabella Coletta, Lorenzo Polenzani, Giorgina Mangano, Maria Alessandra Alisi, (unknown), Antonio Giachetti, Marina Ziche, Sandra Donnini	41
17	EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 2011 ·Oncogene ·Sandra Donnini, Francesca Finetti, Erika Terzuoli, Antonio Giachetti, Miguel A. Íñiguez, Hiromi Hanaka, Manuel Fresno, Olof Rådmark, Marina Ziche	24
18	Inhibition of Hypoxia Inducible Factor-1α by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis 2010 ·Clinical Cancer Research ·Erika Terzuoli, Sandra Donnini, Antonio Giachetti, Miguel A. Íñiguez, Manuel Fresno, Giovanni Melillo, Marina Ziche	59
19	Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion 2010 ·Cancer Research ·Erika Terzuoli, Maura Puppo, Annamaria Rapisarda, Badarch Uranchimeg, Liang Cao, Angelika M. Burger, Marina Ziche, Giovanni Melillo	95
20	Sulfhydryl Angiotensin-Converting Enzyme Inhibitor Promotes Endothelial Cell Survival through Nitric-Oxide Synthase, Fibroblast Growth Factor-2, and Telomerase Cross-Talk 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Sandra Donnini, Erika Terzuoli, Marina Ziche, Lucia Morbidelli	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact